SBRT embedded in low-dose RT plus alphaPD-1 (immuno-EclipseRT, iERT) elicits CD8(+) T cell immunity against bulky tumors via an IFN-I/NK/DC axis. (nature.com)

Authors: Luo R … Lu Y Journal: Nature Communications Published: 2026-07-08 DOI: https://doi.org/10.1038/s41467-026-73683-z